Abstract:Event Abstract Back to Event Separation of patients with schizophrenia and bipolar disorder based on MRI scans: Can machine learning aid in clinical diagnosis? Hugo Schnack1*, Mireille Nieuwenhuis1, Neeltje E. Van Haren1 and Rene Kahn1 1 Brain Center Rudolf Magnus, University Medical Center Utrecht, Psychiatry, Netherlands Background: The question of whether brain changes in schizophrenia and bipolar disorder are similar is not only relevant regarding their possible genetic and biological overlap; it also has clinical and diagnostic implications. Here we address the issue of whether structural MRI brain scans can be used to differentiate the two disorders. In a recent study we built a structural-MRI-based schizophrenia classification model and tested its predictive capacity in an independent test sample [1]. Using two large data sets, we confirmed the feasibility to use structural MRI for individualized prediction whether a subject is a schizophrenia patient or a healthy control, with an accuracy of 70.4%. Although scientifically interesting, the clinical use is limited: these classification models become really useful if they can predict a subject’s future status, or its current status if this cannot be determined by other means. Methods: Structural magnetic resonance 1.5 T whole brain images of 66 patients with schizophrenia, 66 with bipolar disorder, and 66 healthy controls were segmented and further processed to create gray matter density (GMD) maps, reflecting local gray matter tissue presence [2]. These GMD maps were used to train linear Support Vector Machines (SVM) [3]) to separate the three groups (Fig. 1). The validity, or generalizibility, of the models was first tested by leave-one-out cross-validation. Secondly, the models were applied without change to an independent data set acquired on a 3 T scanner that included 46 schizophrenia patients, 47 patients with bipolar disorder and 43 healthy control subjects. Results: Schizophrenia patients could be correctly classified versus healthy subjects with an accuracy of 90%; they could be differentiated from bipolar patient with the same level of accuracy, i.e. also 88%. The model separating bipolar patients from healthy control subjects performed worse: 67% of the healthy subjects were correctly classified and only 53% of the bipolar patients (Fig. 1). Application of the 1.5 T models on the 3 T validation set yielded average classification accuracies of 76% (healthy vs schizophrenia), 66% (bipolar vs schizophrenia) and 61% (healthy vs bipolar). Conclusion: We demonstrated the feasibility to use structural MRI for individualized prediction whether a subject is a schizophrenia patient or not, with an accuracy of 88%. In an independent validation set acquired on a scanner with different field strength the unaltered models performed significantly above chance level, with accuracies of 76% (schizophrenia vs healthy) and 66% (schizophrenia vs bipolar). While the use of MRI to separate schizophrenia patients from healthy subjects has limited clinical value, the accurate separation of schizophrenia patients from bipolar patients could become a diagnostic aid for psychiatrists. The results also indicate that the gray matter pathology differs between schizophrenia and bipolar disorder to such an extent that they can be reliably differentiated using machine learning paradigms. Figure 1 References 1. Nieuwenhuis et al (2012), Neuroimage 61:606-612. 2. Ashburner and Friston (2000), NeuroImage 11:805-821. 3. Vapnik (1999), IEEE Trans Neural Netw 10:988–999. Keywords: machine learning, MRI, Schizophrenia, Bipolar Disorder, Diagnosis, Computer-Assisted Conference: Neuroinformatics 2014, Leiden, Netherlands, 25 Aug - 27 Aug, 2014. Presentation Type: Poster, to be considered for oral presentation Topic: Neuroimaging Citation: Schnack H, Nieuwenhuis M, Van Haren NE and Kahn R (2014). Separation of patients with schizophrenia and bipolar disorder based on MRI scans: Can machine learning aid in clinical diagnosis?. Front. Neuroinform. Conference Abstract: Neuroinformatics 2014. doi: 10.3389/conf.fninf.2014.18.00064 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 25 Apr 2014; Published Online: 04 Jun 2014. * Correspondence: Dr. Hugo Schnack, Brain Center Rudolf Magnus, University Medical Center Utrecht, Psychiatry, Utrecht, Netherlands, h.schnack@gmail.com Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Hugo Schnack Mireille Nieuwenhuis Neeltje E Van Haren Rene Kahn Google Hugo Schnack Mireille Nieuwenhuis Neeltje E Van Haren Rene Kahn Google Scholar Hugo Schnack Mireille Nieuwenhuis Neeltje E Van Haren Rene Kahn PubMed Hugo Schnack Mireille Nieuwenhuis Neeltje E Van Haren Rene Kahn Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.

Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples.

Can Structural MRI Aid in Clinical Classification? A Machine Learning Study in Two Independent Samples of Patients with Schizophrenia, Bipolar Disorder and Healthy Subjects

Separation of Patients with Schizophrenia and Bipolar Disorder Based on MRI Scans: Can Machine Learning Aid in Clinical Diagnosis?

An Optimized Voxel-Based Morphometry MRI Study of the Brain in Patients with First Episode Schizophrenia

Support Vector Machine-Based Classification of First Episode Drug-Naïve Schizophrenia Patients and Healthy Controls Using Structural MRI.

Regional Structural Characterization of the Brain of Schizophrenia Patients

Classification of Schizophrenic Patients and Healthy Controls Using Multiple Spatially Independent Components of Structural MRI Data

Multisite Machine Learning Analysis Provides a Robust Structural Imaging Signature of Schizophrenia Detectable Across Diverse Patient Populations and Within Individuals.

Diagnosis of Schizophrenia and its Subtypes Using MRI and Machine Learning

Discriminative analysis of schizophrenia using support vector machine and recursive feature elimination on structural MRI images.

Multi-center MRI Prediction Models: Predicting Sex and Illness Course in First Episode Psychosis Patients.

Voxel-based morphometric analysis on the structure of white matter in schizophrenic patients

Improving the predictive potential of diffusion MRI in schizophrenia using normative models-Towards subject-level classification

A Voxel-Based Morphometric Analysis of Structural Gray Matter Abnormality in Schizophrenia

Identifying schizophrenia using whole-brain different imaging modalities via a multivariate pattern analysis

A Systematic Characterization of Structural Brain Changes in Schizophrenia

Detecting Schizophrenia at the Level of the Individual: Relative Diagnostic Value of Whole-Brain Images, Connectome-Wide Functional Connectivity and Graph-Based Metrics

Clinical Prediction from Structural Brain MRI Scans: A Large-Scale Empirical Study

A Study on the Classification of Schizophrenia Based on Single Gray Matter Networks

Poster #56 CLASSIFICATION OF SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS FROM STRUCTURAL MRI SCANS VERIFIED IN TWO LARGE INDEPENDENT SAMPLES

Subcortical Brain Volume Abnormalities in 2028 Individuals with Schizophrenia and 2540 Healthy Controls Via the ENIGMA Consortium